ST. LOUIS, April 12, 2012 /PRNewswire/ -- K-V
Pharmaceutical Company (the "Company") (NYSE: KVa/KVb) today
announced that Greg Divis, President
and CEO, and Tom McHugh, Chief
Financial Officer, will present at the Imperial Capital 2012
Healthcare Investor Forum on Tuesday, April
17, 2012 at 2:00 p.m. EDT at
The New York Palace Hotel in New York
City.
Following the conclusion of the formal presentation, two
industry experts will join the Company's management to take
questions from the audience.
The presentation will be available via webcast. To access
the web cast, please go to the investor relations portion of the
Company's website at www.kvpharmaceutical.com and visit the
"Upcoming Investor Events" tab. Please log-in at least 10
minutes prior to the start time to ensure a connection. The webcast
of the presentation will be archived for thirty days.
About K-V Pharmaceutical Company
K-V Pharmaceutical Company is a specialty branded pharmaceutical
company with a primary focus in the area of women's
healthcare. As such, we are committed to advancing the
health of women across all the stages of their lives.
For further information about K-V Pharmaceutical Company, please
visit the Company's corporate Website at
www.kvpharmaceutical.com.
SOURCE K-V Pharmaceutical Company